JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 21, 2004; DOI: 10.1124/jpet.104.068775


0022-3565/04/3112-476-484$20.00
JPET 311:476-484, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.068775v1
311/2/476    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prime-Chapman, H. M.
Right arrow Articles by Hirst, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prime-Chapman, H. M.
Right arrow Articles by Hirst, B. H.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Differential Multidrug Resistance-Associated Protein 1 through 6 Isoform Expression and Function in Human Intestinal Epithelial Caco-2 Cells

Hannah M. Prime-Chapman, Richard A. Fearn, Anne E. Cooper, Vanessa Moore, and Barry H. Hirst

Institute for Cell and Molecular Biosciences (H.M.P.-C., R.A.F., B.H.H.), University of Newcastle, Medical School, Newcastle upon Tyne, United Kingdom; and Pharmaceutical and Analytical Research and Development (V.M.) and Department of Physical and Metabolic Science (A.E.C.), AstraZeneca Research and Development Charnwood, Loughborough, Leicestershire, United Kingdom

Multidrug resistance-associated protein (MRP) isoforms 1 through 6 mRNA are expressed in the human intestine and Caco-2 cells. In Caco-2 cells, the rank order for mRNA expression was MRP2 ≥ MRP6 > MRP4 ≥ MRP3 > MRP1 = MRP5. The functional expression of MRP-like activity was quantified as the efflux of the fluorescent probe calcein from confluent, polarized monolayers of Caco-2 cells. Calcein efflux was sensitive to temperature, energy depletion, and the MRP antagonist MK571 [3-[[3-[2-(7-chloroquinolin-2-yl)vinyl]phenyl]-(2-dimethylcarbamoylethylsulfanyl)methylsulfanyl] propionic acid]. Calcein efflux across the apical membrane of Caco-2 cells exceeded that across the basolateral by approximately 2-fold, correlating with the apical localization of MRP2 visualized by immunocytochemical staining. T84 cells do not express MRP2 and show a predominance of basolateral calcein efflux over apical efflux. MRP3 was localized by immunocytochemical staining to the basolateral membrane. MRP1 staining was not localized to either membrane domain and MRP5 staining was not detected. Thus, basolateral calcein efflux may reflect a function of MRP3 or MRP4 and 6 inferred by their basolateral localization in other tissues. Basolateral, but not apical, calcein efflux was sensitive to glutathione depletion with buthioninesulfoximine, indicating that whereas MRP2-mediated apical efflux is independent of glutathione, basolateral efflux is glutathione-dependent. Benzbromarone, probenecid, pravastatin, and diclofenac were able to inhibit both apical and basolateral calcein efflux. The apical calcein efflux in Caco-2 cells was selectively sensitive to indomethacin and propranolol, but not verapamil or erythromycin, whereas the converse was observed for basal efflux. The differential pharmacological sensitivity of apical (MRP2) and basolateral calcein efflux provides tools for dissecting MRP isoform functional roles.


Received for publication March 22, 2004
Accepted June 21, 2004.

Address correspondence to: Prof. Barry H. Hirst, Institute for Cell and Molecular Biosciences, University of Newcastle, Medical School, Newcastle upon Tyne NE2 4HH, UK. E-mail: barry.hirst{at}ncl.ac.uk




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. Fan, S. Liu, Y. Du, J. Morrison, R. Shipman, and K. S. Pang
Up-Regulation of Transporters and Enzymes by the Vitamin D Receptor Ligands, 1{alpha},25-Dihydroxyvitamin D3 and Vitamin D Analogs, in the Caco-2 Cell Monolayer
J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 389 - 402.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. S. Lagas, C. M. M. van der Kruijssen, K. van de Wetering, J. H. Beijnen, and A. H. Schinkel
Transport of Diclofenac by Breast Cancer Resistance Protein (ABCG2) and Stimulation of Multidrug Resistance Protein 2 (ABCC2)-Mediated Drug Transport by Diclofenac and Benzbromarone
Drug Metab. Dispos., January 1, 2009; 37(1): 129 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Pazos, D. Siccardi, K. L. Mumy, J. D. Bien, S. Louie, H. N. Shi, K. Gronert, R. J. Mrsny, and B. A. McCormick
Multidrug Resistance-Associated Transporter 2 Regulates Mucosal Inflammation by Facilitating the Synthesis of Hepoxilin A3
J. Immunol., December 1, 2008; 181(11): 8044 - 8052.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. MacLean, U. Moenning, A. Reichel, and G. Fricker
Closing the Gaps: A Full Scan of the Intestinal Expression of P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance-Associated Protein 2 in Male and Female Rats
Drug Metab. Dispos., July 1, 2008; 36(7): 1249 - 1254.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. Poquet, M. N. Clifford, and G. Williamson
Transport and Metabolism of Ferulic Acid through the Colonic Epithelium
Drug Metab. Dispos., January 1, 2008; 36(1): 190 - 197.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y. Lai, L. Xing, G. I. Poda, and Y. Hu
Structure-Activity Relationships for Interaction with Multidrug Resistance Protein 2 (ABCC2/MRP2): The Role of Torsion Angle for a Series of Biphenyl-Substituted Heterocycles
Drug Metab. Dispos., June 1, 2007; 35(6): 937 - 945.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. E. Taub, L. Podila, D. Ely, and I. Almeida
FUNCTIONAL ASSESSMENT OF MULTIPLE P-GLYCOPROTEIN (P-GP) PROBE SUBSTRATES: INFLUENCE OF CELL LINE AND MODULATOR CONCENTRATION ON P-GP ACTIVITY
Drug Metab. Dispos., November 1, 2005; 33(11): 1679 - 1687.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. J. Dilda, A. S. Don, K. M. Tanabe, V. J. Higgins, J. D. Allen, I. W. Dawes, and P. J. Hogg
Mechanism of Selectivity of an Angiogenesis Inhibitor From Screening a Genome-Wide Set of Saccharomyces cerevisiae Deletion Strains
J Natl Cancer Inst, October 19, 2005; 97(20): 1539 - 1547.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Letschert, M. Komatsu, J. Hummel-Eisenbeiss, and D. Keppler
Vectorial Transport of the Peptide CCK-8 by Double-Transfected MDCKII Cells Stably Expressing the Organic Anion Transporter OATP1B3 (OATP8) and the Export Pump ABCC2
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 549 - 556.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. J. Xiao, A. B. Foraker, P. W. Swaan, S. Liu, Y. Huang, Z. Dai, J. Chen, W. Sadee, J. Byrd, G. Marcucci, et al.
Efflux of Depsipeptide FK228 (FR901228, NSC-630176) Is Mediated by P-Glycoprotein and Multidrug Resistance-Associated Protein 1
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 268 - 276.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.